AcelRx Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 45   

Articles published

ACRX 7.86 +0.41 (5.50%)
price chart
ACELRX PHARMACEUTICALS INC. : Top-line Data Demonstrate Primary ...
REDWOOD CITY, Calif., May 21, 2013/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...
Top After-Market NASDAQ Movers (FX Energy, NetApp, Canadian Solar ...
The top stocks to gain during after-market hours on the Nasdaq on Tuesday were FX Energy Inc, NetApp Inc, Canadian Solar Inc, DryShips Inc, and AcelRx Pharmaceuticals Inc. The top after-market losers on the Nasdaq were AMAG Pharmaceuticals Inc, ...
ACELRX PHARMACEUTICALS INC : AcelRx Pharmaceuticals to Present at the ...
REDWOOD CITY, Calif., May 16, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...
Related articles »  
AcelRx Pharmaceuticals Given New $11.00 Price Target at Canaccord Genuity ...
AcelRx Pharmaceuticals (NASDAQ: ACRX) traded up 5.50% on Wednesday, hitting $7.86. AcelRx Pharmaceuticals has a 1-year low of $2.27 and a 1-year high of $6.35.
Related articles »  
AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) reaches primary end point on ...
Boston, MA 05/23/2013 (wallstreetpr) - The share prices of AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) surged by 13.44 percent to close at $7.26 per share for the end of last trading session.
AcelRx Pharmaceuticals Q1 13 Earnings Conference Call At 4:30 PM ET
(RTTNews.com) - AcelRx Pharmaceuticals Inc.( ACRX ) will host a conference call at 4:30 PM ETMay 8, 2013, to discuss its Q1 13 earnings results.
Related articles »  
Stocks To Watch: ReneSola Ltd. (ADR), SemiLEDs Corporation, Trina Solar ...
ReneSola Ltd. (ADR) (NYSE:SOL) shares increased 4.86% to $2.59. The company, on May 10, announced it provided modules for use in three community-scale solar power projects in Vermont in the last few months.
AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
REDWOOD CITY, Calif., May 8, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...
AcelRx Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call ...  Seeking Alpha
Related articles »  
AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil ...
REDWOOD CITY, Calif., May 2, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...
Related articles »  
AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results ...
REDWOOD CITY, Calif., May 3, 2013 - /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...
Related articles »